| Name |
Santen Pharmaceutical Co., Ltd. |
Corporate
Headquarters |
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533-8651, Japan
 Map to Head Office
TEL: +81-6-6321-7000
FAX: +81-6-6328-5082 |
| Established |
1890 |
| Incorporated |
1925 |
| Paid-in Capital |
6,670 million yen |
Number of
Employees |
2,946 |
| Representatives |
Akira Kurokawa (President & CEO) |
Stock Exchange
Listings |
Tokyo and Osaka
(Stock code: 4536) |
| Business |
Research and development, production and marketing of pharmaceuticals and medical devices |
Offices,
Laboratories
and Plants |
Nara Research and Development Center, Noto Plant, Shiga Plant, Osaka Plant, approx.90 Marketing Offices in Japan (Tokyo Office, etc.), Beijing Representative Office
See Global Operations for details. |
| Subsidiaries |
Japan:
Claire Co., Ltd., etc.
International:
Santen Inc. (US), Santen Oy (Finland), etc.
See Global Operations for details. |
Back to top |
|
|
